US Plans Shift of Merck COVID Treatment to Commercial Market US Plans Shift of Merck COVID Treatment to Commercial Market

The government will stop distributing free doses of Merck ' s COVID-19 antiviral treatment molnupiravir by the middle of next month and expects it to be sold on the commercial market instead.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news